{"name":"HLB Cell Co., Ltd.","slug":"hlb-cell-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-01-30","type":"regulatory","source":"globenewswire.com","summary":"Elevar Therapeutics Announces FDA Acceptance of New Drug - globenewswire.com","headline":"Elevar Therapeutics Announces FDA Acceptance of New Drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBKZ0tvcjFJZzdGUFU4YW56cXUtRUNNa25xd2JvakFMOXF0Wko1OS05bE9kS1M3OFR4Y2JEVE01ZDg3OVVPcFBXRGE4amIzRndxNGpTSWJ2N3FVTWFlb0lDWWR5eS1xWTJnOC02cTZB0gFyQVVfeXFMTlNKR2tuRjFmVEpvZHpUUzBVbjYtTW94TGFkNXhKdGhnQktsTndOZF9WUmF2UkxfS2VYZmhMQkJnWjIxcVVEdXVKRkZRejIyUjIzSjBqR1FqclZ0Y19SdllnUzY3aHkwSFdJVjV4c2RvTzF3?oc=5","date":"2025-08-13","type":"regulatory","source":"koreabiomed.com","summary":"HLB taps new Elevar CEO to steer FDA push for breakthrough bile duct cancer drug - koreabiomed.com","headline":"HLB taps new Elevar CEO to steer FDA push for breakthrough bile duct cancer drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBaUkdOQThibjZ5aEFNT3NES0JRVDR2amFfeDZzZTROU2xENkJPNG5YbGMwcFllWjFtZmxGZF91cjdlSnRZbjBURHB5YmtBYTFnSlBCSm84ODVKR1o2SHJCcmZPR20tSXUyUUdXa3B30gFyQVVfeXFMTzE0OWZwQzl5eTRmd2ZJcUdwVXdnNkVsOXdBbXBfS3BpQTNBV1pDX2szelpMamVYR0VTOHlpMkVrQTh1UjBEWXQySHpxQm9BM2ZiS1VDTkZELWFzRnlMc0tGVm1OUTdZTVVXcWZUU1p1MDRB?oc=5","date":"2025-04-02","type":"regulatory","source":"koreabiomed.com","summary":"HLB folds Life Science unit after FDA blow, takes full control of liver cancer drug - koreabiomed.com","headline":"HLB folds Life Science unit after FDA blow, takes full control of liver cancer drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPTFhCV0FtN2NMZndXaFZKLXFzX184d25qV3ROVklaRHAwcGtlVXo4cXFqdElYS2h2amM3LU5Eb2p3SlNwVF9RLXQ2SVkyVlZTdkpKSVlXMkNkN0VwRDBkbU0ybEE5NWVpRWRiZVZlQlhObXRFM3RvTFdMQi1PbmdFS0VsMDhIR0J3SndFcjRLejRYQ1dKdWttU19ZbDFoQWpp?oc=5","date":"2025-03-25","type":"deal","source":"BioWorld News","summary":"For nearly $2B, Jiangsu Hengrui licenses heart drug to Merck - BioWorld News","headline":"For nearly $2B, Jiangsu Hengrui licenses heart drug to Merck","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOWGJ1S08xa0ZJX3FROE1abjhYamF5M1ZaWW1GeFFJUzlCRE1CNGZLYkRUM3FwajBMNkczeXFqTEh5ZkJ4NEFNeU5FQ2d0RzY4REZNWHp3OVpSU1Fac3pPSFV3cm9GM0ZqXzB4Ql9nek9VMUhNdFJEdGlISWxMYllsaWhFRy1McUV0X2FreWcyTXFSSEV0TlNZUjNiaWYtaXZhVnVvcms0VVVnUlBBMUY4NFVydVdEbkFwQkdoQVdScVhJckNxZzMw?oc=5","date":"2024-12-20","type":"deal","source":"PR Newswire","summary":"Verismo Therapeutics Completes Merger to Accelerate Clinical Development - PR Newswire","headline":"Verismo Therapeutics Completes Merger to Accelerate Clinical Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQZ3VIbDZCelllUXMzMUxFdWdkNzV2RzREVGdRR0t5SjRuQnFudW9aSEhVanlLSldoeDcxeXphSTFmRWl5VWF0V1pwVldfQ3cwRFpESmNuVUhvWVZWWUVXWXg1V3BMUndPT3NYR2ZQY0ttVktXYUw1UHlYVGsxZVRYZnJvTVZJMDNNeE5TZ1c4dUY4RWhfSFRZelNfMU0wRmt5dVQ2Tw?oc=5","date":"2024-12-10","type":"pipeline","source":"BioWorld News","summary":"NMPA clears drugs from Innovent/Hutchmed, Hengrui, Henlius, Luye - BioWorld News","headline":"NMPA clears drugs from Innovent/Hutchmed, Hengrui, Henlius, Luye","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNZTFOYUlUR0s5b2tBMmNMSHJxQzBQczhseXlIOHQyVy1SY3FSaE1zTDlZVFlLU09JbUFUUktYZFpUYVl2cmpCdEZxb0sweGlnWW9tTTR4a0I0SlR6U3ZjUDhDQms2eGVyejkwcXBYOENCcl95cmttWU4wX2RBMUxFMWF5RDY5eml1MWcwSXh5c3RUWENVSmx1eV9mNA?oc=5","date":"2024-12-04","type":"deal","source":"BioWorld News","summary":"Elevar nabs Relay’s FGFR2 rare cancer drug in $500M deal - BioWorld News","headline":"Elevar nabs Relay’s FGFR2 rare cancer drug in $500M deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wJBVV95cUxPdC1YNmgzaGRXdTV1SzFqU0wtQ05XS0IxcF9sd3Q4cVViVGpUNC1aci1LTWlPWFZuWXB5ZG9BWnNaSE5icV93T0tkRG0wWFQ5VzJLNXRYVjQ2eFZUODdGMVVoTkNUWk9SYlRCNHhmZThrdDFJYnE2TmMyaGd1UzBzOXNhb2QyQ05JUEF0ZVUxX05hZ3RSWkhIV2dnNjZqOEZpekFZSUxLNWJzTzh5Nkx0anVhNzYzdklBcGtFeEEyb3hGNWhidXJuUUNqbEhVSm0tQVhqZ2tJYXNUbEtzZWdyOGMwVnVkYmtHdkVPSEYtcEVuaXU3LW5DNHhDZHNMb0lwYlZ0RmNQa2dVa1ZUX0N0X2x4c0FFYThOZjBBX096X282ZjNCYUR2SDk2OUYtb09TSTFXZGN1M0pTRDBmMHBoTDRCOXZ4NThRYkRmaTVMYVpZWHBvTnJSOFBxSHJ4STlRUDNJ?oc=5","date":"2023-10-17","type":"pipeline","source":"globenewswire.com","summary":"Jiangsu Hengrui Pharma and Elevar Therapeutics Announce - globenewswire.com","headline":"Jiangsu Hengrui Pharma and Elevar Therapeutics Announce","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgJBVV95cUxQVGpzVFNqYVB4cWl2VWYyVFJpT2xrY0Yyam56ZEwySDZsZ1lvV3B4elZ1cXNRcXZnUkF3WXVid0kwRHBza0RwVk0tSWtWMmtXaVM5eEt5aERGMW9aZzMtWkJzZ29jSzJObE0xYXFJQ1pFRFJhRHNFc3Vuak5pblpUd2VKM1o0Z2FrTmZvSHpKOHZ0WThrT2thRFRKOTJ3al9NYVV5UU5QSVp6aGFMMkJhNGhrS3RwWjFpRGxxREJZRUNxSUNqT1Bncy1rcFFVamppV3ZhM0hRMGtTR1M3WVJQcUpaN1BoR19oWEFDdHBXZTNJVGNiVkw3LVNBcW5COENqUWwtUXlZcjZoTmM5QzBZS2NmZ043aG9EbUJtZjZ0UmZxSmJhMG1icFNsZTRsMHp6LUZsNXFHOEZzRlFQVXpoc20xVWhCRXV4S29rOHF3?oc=5","date":"2023-09-07","type":"pipeline","source":"PR Newswire","summary":"Acute-On-Chronic Liver Failure Market to Register Immense Growth by 2032, Assesses DelveInsight | Key Companies - Grifols, Promethera, GENFIT, RHEACELL, Versantis, Martin GNI Group - PR Newswire","headline":"Acute-On-Chronic Liver Failure Market to Register Immense Growth by 2032, Assesses DelveInsight | Key Companies - Grifol","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1xQlpiVFlIS3A1REQzYVZvSVpZaVMyRV9yUTg0a25fTWFkcFY3QTZXTHdZUldjTGlLS3haUDhMdlUtdEd6c0xfeU9BUkVWVzFiXzZNdlpNWDM2NHM0SS1hUGhYcUVMOGtHRDE4QzhR?oc=5","date":"2023-08-24","type":"pipeline","source":"KED Global","summary":"HLB signs with Japan's OSCL for exclusive supply of C-Trelin ingredient - KED Global","headline":"HLB signs with Japan's OSCL for exclusive supply of C-Trelin ingredient","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE4yWHZudzllSWZ5Q2Z5Y2FUTUp4TVBmaldKZjNqRGVibHczNEgtR1lvUXhMa08yVE54djQxMDhmaGRIemMxRGZ1cHFtcDlYeWFlem95XzFJSFBFRDJNdmgxSHpDRExjYTRiMFNqXzVB?oc=5","date":"2023-05-19","type":"regulatory","source":"KED Global","summary":"HLB submits new drug application to FDA for Rivoceranib liver cancer drug - KED Global","headline":"HLB submits new drug application to FDA for Rivoceranib liver cancer drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQa1JLMk1DUFNmUzVzWFVScWtMWTNWQnRUclBnWjZKVzdnamwwTFJOZUdYZmhvS29yaG5XRkR0Z3phYVR2RV9UR2ktNDNseWNQWUhBQXVJd3haSGE4aGkyQzJyWnNtQmVCUEZrZWtpNmtaN3pNVzJkVE52UGVLRzNjajhhQnhRNWFBSEUyVGJjemxMVjF1bENybk1KM3J4Mml5YkxMMGh5YTM3elFLNnNvcHAySnl3Zw?oc=5","date":"2021-10-13","type":"pipeline","source":"citybiz","summary":"Verismo Therapeutics Appoints Laura Johnson, Ph.D. as Chief Scientific Officer - citybiz","headline":"Verismo Therapeutics Appoints Laura Johnson, Ph.D. as Chief Scientific Officer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}